GSK3B AS A TARGET FOR PRO-NEURONAL SURVIVAL IN CNS NEURONS

$245,567P20FY2006RRNIH

University Of Louisville, Louisville KY

Investigators

Michal Hetmancontact

Linked publications & trials

Paper 27403345 Paper 27085393 Paper 26843650 Paper 25975172 Paper 25077610 Paper 25014412 Paper 24323683 Paper 24294909 Paper 23659896 Paper 23590601 Paper 23466931 Paper 23186206 Paper 22884499 Paper 22873727 Paper 22743801 Paper 22708983 Paper 22445934 Paper 22307075 Paper 22245387 Paper 22181016 Paper 22119625 Paper 21970599 Paper 21933012 Paper 21799908 Paper 21740131 Paper 21697451 Paper 21679705 Paper 21638341 Paper 21517844 Paper 21508230 Paper 21360237 Paper 21168495 Paper 21156172 Paper 21098478 Paper 20849530 Paper 20708053 Paper 20627820 Paper 20623527 Paper 20590523 Paper 20557419 Paper 20434524 Paper 20375135 Paper 20338826 Paper 20302862 Paper 20181596 Paper 19955386 Paper 19886808 Paper 19860657 Paper 19795370 Paper 19766612 Paper 19703551 Paper 19663807 Paper 19635528 Paper 19553492 Paper 19442162 Paper 19331515 Paper 19306380 Paper 19270266 Paper 19236864 Paper 19196178 Paper 19170182 Paper 19003792 Paper 18986225 Paper 18986224 Paper 18971483 Paper 18673210 Paper 18665890 Paper 18632933 Paper 18612314 Paper 18486695 Paper 18455876 Paper 18315559 Paper 18305256 Paper 18171689 Paper 18092342 Paper 18065156 Paper 17917587 Paper 17872503 Paper 17692844 Paper 17678895 Paper 17678647 Paper 17628688 Paper 17592073 Paper 17582154 Paper 17540369 Paper 17425559 Paper 17346980 Paper 17343351 Paper 17316612 Paper 17274982 Paper 17184189 Paper 17161391 Paper 17115911 Paper 17084191 Paper 17005865 Paper 16983667 Paper 16938403 Paper 16932168 Paper 16921543 Paper 16797539

View original record on NIH RePORTER →